Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
06/15/2005 | CN1206220C Process for producing 2-(4-pyridyl) ethanethiol |
06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
06/14/2005 | US6906195 Heat resistance, colorfastness |
06/14/2005 | US6906166 Multicolor; light emitting diodes; polyarylenevinylenes |
06/14/2005 | US6906105 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer |
06/14/2005 | US6906104 Aminediols for the treatment of Alzheimer's disease |
06/14/2005 | US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
06/14/2005 | US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
06/14/2005 | US6906072 Central nervous system disorders |
06/14/2005 | US6906063 For therapy and prophylaxis of thrombosis in a mammal |
06/14/2005 | US6905455 Radioactive member and method of making |
06/14/2005 | CA2308817C Process for preparing 2-phenyl-3-aminopyridine, substituted phenyl derivatives thereof, and salts thereof |
06/14/2005 | CA2101684C Substituted (hetero)aryl compounds, process for their preparation, agents containing them, and their use as safeners |
06/09/2005 | WO2005051941A1 Thione derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same |
06/09/2005 | WO2005051914A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
06/09/2005 | WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof |
06/09/2005 | WO2005051901A1 Anti-cancer agents |
06/09/2005 | WO2005051892A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines |
06/09/2005 | WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
06/09/2005 | WO2005051889A1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents |
06/09/2005 | WO2005051387A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
06/09/2005 | WO2005051386A1 Hmg-coa reductase inhibitors and method |
06/09/2005 | WO2005051373A1 Receptor function regulating agent |
06/09/2005 | WO2005051317A2 Substituted imidazo ring systems and methods |
06/09/2005 | WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof |
06/09/2005 | WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof |
06/09/2005 | WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof |
06/09/2005 | WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
06/09/2005 | WO2005016505A3 Method for the manufacture of cyanopyridines and catalysts suitable therefor |
06/09/2005 | WO2003088897A3 Fab i inhibitors |
06/09/2005 | US20050124808 Using nickel or palladium coupling catalyst containing phosphine or phosphite ligands |
06/09/2005 | US20050124807 oxidation of a hetero alcohol in presence od an 2,2,6,6-teraalkylpiperidin-1-oxy comound |
06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
06/09/2005 | US20050124679 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
06/09/2005 | US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt |
06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
06/09/2005 | US20050124654 Compounds and methods of use |
06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
06/09/2005 | US20050124625 For example, ((2R,5S)-4-(8-cyano-quinolin-5-yl)-2,5-dimethyl-piperazine-1-carboxylic acid(4-trifluoromethyl-pyridin-3-yl)-amide); use in treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders |
06/09/2005 | US20050124610 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
06/09/2005 | US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism |
06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
06/09/2005 | US20050124209 Illuminated electrical cords and outlets |
06/09/2005 | US20050124069 Transfection reagents |
06/09/2005 | US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
06/09/2005 | US20050123475 Preparation and use of alkylating agents |
06/09/2005 | DE10351842A1 m-Diaminobenzole und deren Säureaddukte sowie deren Verwendung in Färbemitteln m-diaminobenzenes and their acid adducts, and their use in colorants |
06/09/2005 | CA2547430A1 Receptor function regulating agent |
06/09/2005 | CA2547281A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines |
06/09/2005 | CA2547020A1 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier |
06/09/2005 | CA2546709A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
06/09/2005 | CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof |
06/09/2005 | CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof |
06/09/2005 | CA2546142A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
06/09/2005 | CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof |
06/09/2005 | CA2545659A1 Bicyclic inhibitors of mek |
06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
06/08/2005 | EP1538145A1 Process for production of phenoxy-substituted 2-pyridone compounds |
06/08/2005 | EP1537088A2 Substituted pyridines or pyrimidines, method for their production, agents containing said substances and the use thereof as pesticides |
06/08/2005 | EP1537085A1 Oxytocin inhibitors |
06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
06/08/2005 | EP1537076A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
06/08/2005 | EP1537072A1 Substituted aminoethers for the treatment of alzheimer s disease |
06/08/2005 | EP1537068A1 Materials and methods for treating hypercholesterolemia |
06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
06/08/2005 | EP1392673B1 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
06/08/2005 | EP1252133B1 Pharmaceutical compounds |
06/08/2005 | EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
06/08/2005 | EP1057816B1 Method for producing heteroaromatic aldehydes |
06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
06/08/2005 | EP0849256B1 Amide compounds and use of the same |
06/08/2005 | CN1625603A Genetic polymorphisms in the preprotachykinin gene |
06/08/2005 | CN1625549A Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
06/08/2005 | CN1623987A Novel processes for preparing torsemide |
06/08/2005 | CN1623986A Method for preparing synthetic methyl pyridine |
06/08/2005 | CN1623660A Preparation process of load type synthetic methyl pyrdine catalyst |
06/08/2005 | CN1205202C N-carbanilides used as pesticides |
06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
06/08/2005 | CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
06/08/2005 | CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
06/07/2005 | US6903220 Synthesis of chiral 2-alkyl amino acids |
06/07/2005 | US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions |
06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
06/07/2005 | US6903118 Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
06/02/2005 | WO2005049609A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
06/02/2005 | WO2005049604A2 Antithrombotic aromatic ethers |
06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
06/02/2005 | WO2005049574A1 Androgen receptor modulators |
06/02/2005 | WO2005049573A1 Phenyl derivatives as ppar agonists |
06/02/2005 | WO2005049572A1 Benzannelated compounds as ppar activators |